Cell Signalling and Therapeutics (C7118)

15 credits, Level 6

Autumn teaching

Explore the major signalling pathways in cells, and how perturbations of these can result in disease processes such as cancer.

You will learn how knowledge of these pathways has led to the design and use of specific pharmacological agents, targeting the pathways for therapeutic intervention.

The signalling pathways covered will include:

  • RTKs
  • LMTK3
  • MAPK kinase pathways
  • PI-3-kinase and PKB
  • Jak/Stat pathways
  • integrins.


100%: Lecture


30%: Coursework (Test)
70%: Examination (Computer-based examination)

Contact hours and workload

This module is approximately 150 hours of work. This breaks down into about 30 hours of contact time and about 120 hours of independent study. The University may make minor variations to the contact hours for operational reasons, including timetabling requirements.

We regularly review our modules to incorporate student feedback, staff expertise, as well as the latest research and teaching methodology. We’re planning to run these modules in the academic year 2024/25. However, there may be changes to these modules in response to feedback, staff availability, student demand or updates to our curriculum. We’ll make sure to let you know of any material changes to modules at the earliest opportunity.


This module is offered on the following courses: